Загрузка...

Targeting eosinophils: severe asthma and beyond

Recent research in the field of bronchial asthma has mainly focused on eosinophilic disease phenotype. Several trials proved the efficacy and safety profile of eosinophils and interleukin (IL)-5 targeting molecules, currently approved for severe asthma and available on the market. They include mepol...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Drugs Context
Главные авторы: Caminati, Marco, Menzella, Francesco, Guidolin, Lucia, Senna, Gianenrico
Формат: Artigo
Язык:Inglês
Опубликовано: BioExcel Publishing Ltd 2019
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6668506/
https://ncbi.nlm.nih.gov/pubmed/31391853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212587
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!